These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32381131)

  • 41. Time to positivity of blood cultures in bloodstream infections with
    Bläckberg A; Lundberg K; Svedevall S; Nilson B; Rasmussen M
    Infect Dis (Lond); 2023 May; 55(5):333-339. PubMed ID: 36847483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
    Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection.
    Willmann M; Kuebart I; Vogel W; Flesch I; Markert U; Marschal M; Schröppel K; Autenrieth IB; Hölzl F; Peter S
    J Infect; 2013 Nov; 67(5):416-23. PubMed ID: 23817209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Prognostic Value of Time to Positivity of
    Chen CP; Yang YY; Tsai IT; Hsu YC
    J Acute Med; 2023 Dec; 13(4):137-143. PubMed ID: 38090119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeated Blood Cultures in Pediatric Febrile Neutropenia: Would Following the Guidelines Alter the Outcome?
    Petty LA; Sokol EA; Bartlett AH; McNeer JL; Alexander KA; Pisano J
    Pediatr Blood Cancer; 2016 Jul; 63(7):1244-9. PubMed ID: 26970419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
    Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
    Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
    Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
    Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between dementia and reduced walking ability and 30-day mortality in patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia.
    Chapelet G; Boureau AS; Dylis A; Herbreteau G; Corvec S; Batard E; Berrut G; de Decker L
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2417-2422. PubMed ID: 28801698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short time to positivity of blood culture predicts mortality and septic shock in bacteremic patients: a systematic review and meta-analysis.
    Hsieh YC; Chen HL; Lin SY; Chen TC; Lu PL
    BMC Infect Dis; 2022 Feb; 22(1):142. PubMed ID: 35144551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time to Blood Culture Positivity: An Independent Predictor of Mortality in
    Bläckberg A; Svedevall S; Lundberg K; Nilson B; Kahn F; Rasmussen M
    Open Forum Infect Dis; 2022 Jun; 9(6):ofac163. PubMed ID: 35615297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time to positivity in bloodstream infection is not a prognostic marker for mortality: analysis of a prospective multicentre randomized control trial.
    Hamilton F; Evans R; Ghazal P; MacGowan A
    Clin Microbiol Infect; 2022 Jan; 28(1):136.e7-136.e13. PubMed ID: 34111588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic accuracy of time to first positivity of blood cultures for predicting severe clinical outcomes in children with pneumonia-related bacteremia.
    Zhang Y; Lin J; Shi Q; Li C; Liu J; Dai J
    J Investig Med; 2020 Oct; 68(7):1241-1249. PubMed ID: 32848047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of time to positivity of pediatric blood cultures obtained within the first year of life and in later years.
    Sato H; Nakao A; Sato K; Otomo Y; Niijima S; Shimizu T
    J Infect Chemother; 2020 Aug; 26(8):813-817. PubMed ID: 32312620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
    Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Wang SS; Lee NY; Hsueh PR; Huang WH; Tsui KC; Lee HC; Wu CJ; Chang CM; Huang CC; Huang CF; Ko WC
    J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.
    Krcmery V; Spanik S; Mrazova M; Trupl J; Grausova S; Grey E; Kukuckova E; Sulcova M; Krupova I; Koren P
    Int J Infect Dis; 2002 Mar; 6(1):69-73. PubMed ID: 12044306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia.
    Kim SH; Yoon YK; Kim MJ; Sohn JW
    J Antimicrob Chemother; 2013 Dec; 68(12):2890-7. PubMed ID: 23825380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Escherichia coli bacteraemias in intensive care unit patients.
    Wujtewicz MA; Śledzińska A; Owczuk R; Wujtewicz M
    Anaesthesiol Intensive Ther; 2016; 48(3):171-4. PubMed ID: 27188963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.